openPR Logo
Press release

Investigation announced for Investors in shares of NanoViricides, Inc. (NYSE: NNVC)

07-24-2020 04:39 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in NanoViricides, Inc. (NYSE: NNVC) shares over potential securities laws violations by NanoViricid

An investigation for investors in NanoViricides, Inc. (NYSE: NNVC) shares over potential securities laws violations by NanoViricid

An investigation was announced over possible securities laws violations by NanoViricides, Inc. in connection with certain financial statements.

Investors who purchased shares of NanoViricides, Inc. (NYSE: NNVC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by NanoViricides, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Shelton, CT based NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.

Shares of NanoViricides, Inc. (NYSE: NNVC) spiked from under $2 per share in mid December 2019 to $17.77 per share on January 27, , respectively to as high as $19.20 per share on January 31, 2020, and declined to as low as $4.60 per share. On March 25, 2020.

On July 23, 2020, NYSE: NNVC shares closed at $6.64 per share.

Those who purchased shares of NanoViricides, Inc. (NYSE: NNVC) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of NanoViricides, Inc. (NYSE: NNVC) here

News-ID: 2095942 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for NanoViricides

Nanomedicines Market Prediction and Analysis Offered By New Study | Abbott, GE H …
The primary goal of the Nanomedicines Market report is to provide readers with a low-cost understanding of the industry that has been examined utilising primary and secondary research methods. This Nanomedicines Market report's primary goal is to provide a comprehensive overview and strategic analysis of the parent industry. The research comprehensively analyses each segment as well as any associated sub-segments that are present in the market. By analysing the market's
Ebola Treatment Market Projected to Show Strong Growth | GlaxoSmithKline, NanoVi …
HTF MI Analyst have added a new research study on Title Ebola Treatment Market - Global Outlook and Forecast 2021-2027 with detailed information of Product Types [Vaccine (Under Trials) & Drugs (Under Trials)], Applications [Hospitals, Ambulatory Surgery Centres, Specialized Clinics & Army Camps (Veteran Facilities)] & Key Players Such as Arbutus Biopharma, GlaxoSmithKline, Johnson & Johnson Services, Hemispherx Biopharma, BioCryst Pharmaceuticals, NanoViricides, NewLink Genetics, Chimerix, Sarepta Therapeutics & Mapp Biopharmaceutical
Nanostructured Drug Market Report 2022, Size, Share, Outlook, and Top Key player …
Nanostructured Drug Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Nanostructured Drug Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis. 𝐓𝐨 𝐠𝐞𝐭 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬
Global Nanomedicine Market Research And Forecast by 2030 | Pfizer Inc., Nanother …
‘Nanomedicine Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take on. The market research report helps gain a truly global perspective of the nanomedicine industry as it covers 60
Investigation announced for NYSE: NNVC shares over potential Wrongdoing at NanoV …
An investigation on behalf of investors in shares of NanoViricides, Inc. (NYSE: NNVC) was announced over potential breaches of fiduciary duties by certain officers and directors at NanoViricides, Inc. Investors who purchased shares of NanoViricides, Inc. (NYSE: NNVC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain NanoViricides, Inc. (NYSE: NNVC officers and directors
Biosurveillance Market is forecast to reach USD 5.62 Billion by 2027 | Bitscopic …
Reports and Data has added a new investigative and thorough research report on the Biosurveillance market titled “Global Biosurveillance Market Insights 2020” with comprehensive details about product types, applications, and key market players. The report also analyses emerging trends and offers a detailed overview of the market dynamics. The report considers the COVID-19 pandemic as a key influencing factor of the Biosurveillance market. The market has been drastically affected by